{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:32:29Z","timestamp":1761921149296,"version":"build-2065373602"},"reference-count":27,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Children"],"abstract":"<jats:p>The last two decades have seen an increase in the incidence of inflammatory bowel disease (IBD) in many regions of the world, which has had a significant impact on both the social and economic burden of governments and healthcare systems. The aim of this study was to determine the level of hospitalization and outpatient treatment costs for children and adolescents with Crohn\u2019s disease and ulcerative colitis, depending on age, location, and activity of the disease. Methods were a retrospective analysis of the medical documentation of 240 children with IBD, hospitalized in the Gastroenterology Ward, Department of Pediatrics Medical University of Silesia (Katowice, Poland), along the three years follow up. The costs of treatment consisted of calculations of the supply of oral and intravenous drugs, calculations of the costs of laboratory tests, imaging, and consultations, as well as person-day costs. The most important results, determined with high costs of IBD treatment, are associated with younger age, high disease activity, localization in the small intestine in Crohn\u2019s disease (CD), and inflammatory changes in the entire colon in Ulcerative Colitis (UC). During the observation, it was noticed that the shortening of the hospitalization time did not significantly affect the total costs, which remained at a stable level.<\/jats:p>","DOI":"10.3390\/children10071112","type":"journal-article","created":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T01:42:02Z","timestamp":1687830122000},"page":"1112","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Costs of Healthcare for Children with Inflammatory Bowel Diseases (IBD) in Poland"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1201-0674","authenticated-orcid":false,"given":"Gra\u017cyna","family":"Markiewicz-\u0141oskot","sequence":"first","affiliation":[{"name":"Department of Nursing and Social Medical Problems, School of Health Sciences in Katowice, Medical University of Silesia in Katowice, Medyk\u00f3w 12 Str., 40-751 Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2114-5108","authenticated-orcid":false,"given":"Wojciech","family":"Chlebowczyk","sequence":"additional","affiliation":[{"name":"Department of Nursing and Social Medical Problems, School of Health Sciences in Katowice, Medical University of Silesia in Katowice, Medyk\u00f3w 12 Str., 40-751 Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1798-4133","authenticated-orcid":false,"given":"Tomasz","family":"Holecki","sequence":"additional","affiliation":[{"name":"Department of Health Economics and Health Management, School of Public Health in Bytom, Medical University of Silesia in Katowice, Piekarska 18 Str., 41-902 Bytom, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,6,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nrgastro.2015.150","article-title":"The global burden of IBD: From 2015 to 2025","volume":"12","author":"Kaplan","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(19)30333-4","article-title":"The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017. A systemiatic analysis for the Global Burden of Disease Study 2017","volume":"5","author":"Naghavi","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.33590\/emjgastroenterol\/10312720","article-title":"Making the Invisible Visible, The Hidden Cost of Paediatric Inflammatory Bowel Disease","volume":"8","author":"Turner","year":"2019","journal-title":"EMJ Gastroenterol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/jcag\/gwy054","article-title":"The impact of Inflammatory Bowel Disease in Canada 2018: Epidemiology","volume":"2","author":"Kaplan","year":"2019","journal-title":"J. Can. Assoc. Gastroenterol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.3748\/wjg.v24.i25.2741","article-title":"A current global trends in the incidence of pediatric\u2014Onset inflammatory bowel disease","volume":"24","author":"Schwarz","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_6","unstructured":"(2017). Act on Healthcare Services Financed from Public Funds, Logbook."},{"key":"ref_7","first-page":"67","article-title":"Financing the Health Protection System in Poland","volume":"5","year":"2014","journal-title":"Contemp. Econ. Electron. Sci. J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/MPG.0000000000000239","article-title":"ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents, European Society of Pediatric Gastroenterology, Hepatology, and Nutrition","volume":"58","author":"Levine","year":"2014","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"IBD Working Group of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) (2005). Inflammatory bowel disease in children and adolescent: Recommendation for diagnosis\u2014The porto criteria. J. Pediatr. Gastroenterol. Nutr., 41, 443.","DOI":"10.1097\/01.MPG.0000163736.30261.82"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/MOG.0000000000000642","article-title":"The burden of cost in inflammatory bowel disease: A medical economic perspective","volume":"36","author":"Beard","year":"2020","journal-title":"Curr. Opin. Gastroenterol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5114\/pg.2016.57883","article-title":"Costs in inflammatory bowel diseases","volume":"11","author":"Petryszyn","year":"2016","journal-title":"Gastroenterol. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1053\/j.gastro.2008.09.012","article-title":"Direct Health Care Costs of Crohn\u2019s Disease and Ulcerative Colitis in United States Children and Adults","volume":"135","author":"Kappelman","year":"2008","journal-title":"Finkelstein Gastroenterol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1002\/ibd.21878","article-title":"Direct Medical Cost of Managing IBD Patients: A Canadian Population-based Study","volume":"18","author":"Bernstein","year":"2012","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/ibd\/izz120","article-title":"Disease-Associated Costs in Children With Inflammatory Bowel Disease: A Systematic Review","volume":"26","author":"Kuenzig","year":"2020","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10198-010-0281-z","article-title":"Health care costs and their predictors of inflammatory bowel diseases in Germany","volume":"12","author":"Prenzler","year":"2011","journal-title":"Eur. J. Health Econ."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3111\/13696998.2015.1021353","article-title":"Direct and indirect healthcare resource utilization and costs associated with ulcerative colitis in a privately-insured employed population in the US","volume":"18","author":"Cohen","year":"2015","journal-title":"J. Med. Econ."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1136\/gut.2004.041616","article-title":"Cost of illness of inflammatory bowel disease in the UK: A single centre retrospective study","volume":"53","author":"Bassi","year":"2004","journal-title":"Gut"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.cgh.2006.02.013","article-title":"Health Care Resource Utilization in Inflammatory Bowel Disease","volume":"4","author":"Longobardi","year":"2006","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/MPG.0b013e318239bc79","article-title":"National burden of pediatric hospitalizations for inflammatory bowel disease: Results from the 2006 Kids\u2019 Inpatient Database","volume":"54","author":"Heaton","year":"2012","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_20","first-page":"352","article-title":"Administrative claims analysis of all-cause annual costs of care and resource utilization by age category for ulcerative colitis patients","volume":"14","author":"Bickston","year":"2008","journal-title":"J. Manag. Care Pharm."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"van der Valk, M.E., Mangen, M.J.J., Severs, M., van der Have, M., Dijkstra, G., van Bodegraven, A.A., Fidder, H.H., De Jong, D.J., van der Woude, C.J., and Romberg-Camps, M.J. (2016). Evolution of Costs of Inflammatory Bowel Disease over Two Years of Follow-Up. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0142481"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/gutjnl-2012-303376","article-title":"Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNF\u03b1 therapy: Results from the COIN study","volume":"63","author":"Mangen","year":"2014","journal-title":"Gut"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.crohns.2013.11.017","article-title":"Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: A cross-sectional, observational study","volume":"8","author":"Gibson","year":"2014","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/apt.15174","article-title":"Systemiatic review: Outcomes and adverse events from randomised trials in Crohn\u2019s disease","volume":"49","author":"Catt","year":"2019","journal-title":"Aliementary Pharmacol. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ibd\/izz104","article-title":"The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn\u2019s & Colitis Foundation","volume":"26","author":"Park","year":"2020","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_26","first-page":"1368","article-title":"Out-of-pocket Cost Burden in Pediatric Inflammatory Bowel Disease: A Cross-sectional Cohort Analysis","volume":"21","author":"Sin","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2165\/00019053-200624080-00006","article-title":"Costs of Inflammatory Bowel Disease in Germany","volume":"24","author":"Stark","year":"2006","journal-title":"Pharmacoeconomics"}],"container-title":["Children"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9067\/10\/7\/1112\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:01:20Z","timestamp":1760126480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9067\/10\/7\/1112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,26]]},"references-count":27,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["children10071112"],"URL":"https:\/\/doi.org\/10.3390\/children10071112","relation":{},"ISSN":["2227-9067"],"issn-type":[{"type":"electronic","value":"2227-9067"}],"subject":[],"published":{"date-parts":[[2023,6,26]]}}}